Westminster Health Forum

Next steps for commissioning specialised services in England

Morning, Thursday, 6th December 2018

Central London

THIS EVENT IS CPD CERTIFIED



This seminar will provide a timely opportunity to discuss next steps for commissioning specialised services in England and the latest developments and priorities for moving towards outcome-based commissioning. It is bringing together policymakers with key stakeholders in the health, social care and public health sectors.


It follows the Government’s recently closed consultation on charging for technology appraisal and highly specialised technology recommendations and miscellaneous amendments to NICE legislation. 


Delegates will discuss the introduction of the new budget impact test by NICE, which assesses the financial impact of a technology over the first 3 years of its use in the NHS and how specialised services will be funded.


Planned sessions will consider key issues for commissioning medicines and priorities for specialised services, including funding, cost effectiveness and reducing variation.


Further sessions will assess the progress of the UK strategy for rare diseases: implementation plan for England, as well as key areas for service delivery in specialised commissioning and the prospects for moving towards more result-based models.



Guests of Honour

Meindert Boysen

Director, Centre for Health Technology Evaluation, NICE

Gareth Arthur

Director, Strategy and Policy, Specialised Services, NHS England

Guests of Honour

Gareth Arthur

Director, Strategy and Policy, Specialised Services, NHS England

Meindert Boysen

Director, Centre for Health Technology Evaluation, NICE

Keynote Speaker

Alastair Kent

Co-chair, UK Rare Diseases Policy Board, Department of Health and Social Care and Chair, Rare Diseases Advisory Group, NHS England

Chair

Glyn Davies MP

Treasurer, All-Party Parliamentary Group on Parkinson’s

Speakers

Simon Swift

Managing Director, Methods Analytics

Dr Caroline Dollery

Chair and Elected GP, NHS Mid Essex Clinical Commissioning Group

Michael Branagan-Harris

Chief Executive Officer, Device Access UK

Bruce Potter

Chairman, Blake Morgan

Sarah Norcross

Co-Chair, Fertility Fairness and Director, Progress Educational Trust

Sue Millman

Chief Executive Officer, Ataxia UK

Dr Paul Catchpole

Director, Value and Access, ABPI